Citadel Advisors’s Lixte Biotechnology Holdings, Inc. Warrants LIXTW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $722 | Sell |
25,231
-801
| -3% | -$23 | ﹤0.01% | 5733 |
|
2025
Q1 | $880 | Sell |
26,032
-1,300
| -5% | -$44 | ﹤0.01% | 5795 |
|
2024
Q4 | $793 | Sell |
27,332
-809
| -3% | -$23 | ﹤0.01% | 5853 |
|
2024
Q3 | $1.46K | Sell |
28,141
-3,981
| -12% | -$207 | ﹤0.01% | 5600 |
|
2024
Q2 | $1.99K | Buy |
+32,122
| New | +$1.99K | ﹤0.01% | 5661 |
|
2023
Q2 | – | Sell |
-11,067
| Closed | -$664 | – | 6185 |
|
2023
Q1 | $664 | Buy |
+11,067
| New | +$664 | ﹤0.01% | 5789 |
|